Tectonic Therapeutic | AVRO - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Celltrion KRW 12.9B 822.77M 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 11.29B 3.15B 2026-06
Gilead Sciences USD 3.85B 1.17B 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Kangmei Pharma CNY -10.94M 15.75M 2026-03
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
MacroGenics USD -33.44M 21.34M 2026-03
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -173K 990K 2025-12
Pfizer USD 667M 4.32B 2026-06
Pharma Mar EUR -1.4M 2.03M 2026-06
Qiagen NV USD 141.4M 24.77M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 2.38B 449M 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Takeda JPY 201.42B 215.04B 2026-06
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 362.83M 474.98M 2026-06